Biotech 2050 Podcast

Biotech 2050 Podcast

Biotech2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years.

Tämä podcast on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi podcastin jaksot saattavat sisältää mainontaa.

Jaksot(261)

Mental health: psychedelics & beyond, Florian Brand, CEO, & Srinivas Rao, CSO, atai Life Sciences

Mental health: psychedelics & beyond, Florian Brand, CEO, & Srinivas Rao, CSO, atai Life Sciences

Synopsis: We recorded this episode in December 2022 with Florian Brand and Srinivas Rao, the Co-Founders and CEO & CSO, respectively, of atai Life Sciences, a biopharmaceutical company that leverage...

5 Huhti 202333min

High-impact oral small molecule therapy in autoimmune disease, Kevin Judice,Co-Founder & CEO,DICE Tx

High-impact oral small molecule therapy in autoimmune disease, Kevin Judice,Co-Founder & CEO,DICE Tx

Synopsis: Kevin Judice is the Co-Founder and CEO of DICE Therapeutics, a clinical-stage biopharmaceutical company developing transformative medicines for autoimmune and inflammatory diseases. Kevin ...

29 Maalis 202328min

A new vision in inflammatory disease: RNAseq led precision medicine, Tariq Kassum, CEO, Celsius Tx

A new vision in inflammatory disease: RNAseq led precision medicine, Tariq Kassum, CEO, Celsius Tx

Synopsis: Tariq Kassum, M.D. is the CEO of Celsius Therapeutics, a company pioneering new precision medicines in inflammatory disease by harnessing the power of single-cell RNA sequencing and human ...

22 Maalis 202326min

Pioneering therapeutics targeting cellular stress pathways, Prakash Raman, President & CEO, Ribon Tx

Pioneering therapeutics targeting cellular stress pathways, Prakash Raman, President & CEO, Ribon Tx

Synopsis: Prakash Raman, Ph.D., is the President and CEO of Ribon Therapeutics, a clinical stage biopharmaceutical company pursuing the development of novel small molecules targeting stress support p...

15 Maalis 202332min

Novel viral vectors in gene therapy, Joel Schneider, CEO & Robert Kotin, Founder, Carbon Biosciences

Novel viral vectors in gene therapy, Joel Schneider, CEO & Robert Kotin, Founder, Carbon Biosciences

Synopsis: Joel Schneider, Ph.D. and Robert Kotin, Ph.D. are the President & CEO and Founder & Chief Technology Advisor, respectively, of Carbon Biosciences, an emerging leader in the development of n...

8 Maalis 202326min

Advancing medicines that matter, Matt Gline, CEO, Roivant Sciences

Advancing medicines that matter, Matt Gline, CEO, Roivant Sciences

Synopsis: Matt Gline is the CEO of Roivant Sciences, a company that delivers innovative medicines and technologies to patients by building Vants – nimble, entrepreneurial biotech and healthcare techn...

1 Maalis 202329min

Transforming chemotherapy for better patient outcomes, Jack Bailey, CEO, G1 Therapeutics

Transforming chemotherapy for better patient outcomes, Jack Bailey, CEO, G1 Therapeutics

Synopsis: Jack Bailey is the CEO of G1 Therapeutics, a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the live...

22 Helmi 202331min

Personalized regenerative medicines, Nabiha Saklayen, PhD, Co-Founder & CEO, Cellino

Personalized regenerative medicines, Nabiha Saklayen, PhD, Co-Founder & CEO, Cellino

Synopsis: Nabiha Saklayen, PhD, is the Co-Founder and CEO of Cellino Biotech, a company working to democratize access to personalized stem cell-based therapies for patients at scale. Nabiha joins hos...

15 Helmi 202329min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
hippokrateen-vastaanotolla
rss-hereilla
tiedekulma-podcast
docemilia
filocast-filosofian-perusteet
rss-tiedetta-vai-tarinaa
rss-totuuden-liepeilla
utelias-mieli
ihanat-ipanat
sotataidon-ytimessa
radio-antro
rss-bios-podcast
rss-vaasan-yliopiston-podcastit
rss-poliisin-mieli
rss-ammamafia
rss-laakaripodi
rss-kasvikutsut